CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,334 | 0 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −3,333 | 3,334 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −3,333 | 6,667 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise | +2,500 | 27,726 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Sale | −1,258 | $11.14 | $14K | 26,468 |
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise | +6,667 | 33,135 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Sale | −3,354 | $11.14 | $37K | 29,781 |
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise | +5,500 | 35,281 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Sale | −2,767 | $11.14 | $31K | 32,514 |
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −2,500 | 0 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −6,667 | 6,667 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −5,500 | 11,000 | ||
| 2025-01-31 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2025-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Restricted Stock Units | +96,377 | 96,377 | ||
| 2024-10-08 | Degnan Chris Chief Financial Officer | Grant or award · Restricted Stock Units | +13,450 | 13,450 | ||
| 2024-10-08 | Degnan Chris Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +74,142 | 74,142 | ||
| 2024-09-09 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,666 | 145,950 | ||
| 2024-09-09 | Schoenberg Mark Chief Medical Officer | Sale | −859 | $13.08 | $11K | 145,091 |
| 2024-09-09 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,666 | 3,334 |
Page 6 of 13 · 244 trades